CDMO Services
Your Molecule Has Met Its Match
Our Culture of Ingenuity Makes the Difference
Cytovance is a fully integrated biologics CDMO that offers innovative development and clinical or commercial drug substance manufacturing of large molecules from mammalian cell culture and microbial fermentation in our modern facilities with state-of-art equipment in single-use technologies up to 2000L. With a 20+ year history of scientific rigor and a solutions-oriented mindset, our team offers you ingenuity end-to-end.
Cytovance Delivers
- True CDMO partnership with an experienced team and responsive culture
- Trusted platform and custom to your molecule manufacturing processes
- Dual expertise in microbial fermentation and mammalian cell culture
- A high manufacturing success rate with complex molecules
- An excellent FDA audit history and a deep understanding of the current regulatory landscape
- Proven global impact with our support in the production and worldwide distribution of an effective Covid-19 vaccine
Our Areas of Expertise
Microbial Services
Strain development to batch and fed batch production with
bacteria and yeast.
Mammalian
Expression of complex recombinant proteins in
mammalian cell culture.
Pre-commercial/Commercial
Process characterization, validation, and support for regulatory success.
Contact Us
Meet Team Cytovance in 2026!
-
– BIO Investment and Growth Summit: March 2-3, Miami Beach, FL
-
– OPCU Large Molecule: March 24, Virtual
-
– World Vaccine Congress: March 30-April 2, Washington D.C. | Booth 536
– PEGS: May 11-15, Boston, MA -
– TIDES USA Oligonucleotide & Peptide Therapeutics: May 11-14, Boston, MA
-
– BIO International Convention: June 22-25, San Diego, CA | Booth 4445
-
– BioProcess International East: September 22-25, Boston, MA
-
– CPHI Europe: October 6-8, Milan, Italy
-
– CDMO Live Americas: October 19-21, Boston, MA
- – OPCU Large Molecule: October 27, Virtual